ResApp Health |
High - |
Low - |
Trades - |
Turnover $0 |
Volume 0 |
| 16 November 2026 at 1:46am | ||||
|
Market Cap (16-Nov) $9,622,170 (1,192nd) |
Close (28-Sep) $0.205 |
Volume (28-Sep) 0 |
Shortsold (21-Sep) 297,501 (0.03%) (573rd) |
|
52w High $0.065 |
52w Low $0.009 |
P/E - |
EPS -0.01 |
Dartford and Gravesham NHS Trust to pilot ResAppDx
RAP released this announcement to the ASX on 1 April 2022, 9:39. The announcement is marked as price sensitive, and is 2 page(s) in length and 109.29kb in size.
You can view all announcements from RAP and see how they appear on a price chart on the announcements page.
At the date of this announcement, RAP was 0.197% short sold according to ASIC data. It was ranked the 421st most shorted stock on the ASX. It remains ranked 573rd as of the latest reported data (21 September 2022).
| Other Recent Announcements from RAP | |
|---|---|
| Removal from Official List | 27 September 2022, 11:58 |
| Scheme of Arrangement has been Implemented | 26 September 2022, 16:28 |
| Ceasing to be a substantial holder | 20 September 2022, 8:09 |
| Dartford and Gravesham NHS Trust to pilot ResAppDx | 1 April 2022, 9:39 |
| COVID-19 Investor Presentation | 22 March 2022, 12:58 |
| Reinstatement to Official Quotation | 22 March 2022, 9:40 |
| ResApp announces positive results of COVID-19 screening test | 22 March 2022, 9:39 |
If you were already registered, log in here.